AG
ATRS

Aperio Group’s Antares Pharma, Inc. ATRS Stock Holding History

Aperio Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$149K Buy
37,381
+4,105
+12% +$13.3K ﹤0.01% 2355
2020
Q3 		$90K Buy
33,276
+7,329
+28% +$20.3K ﹤0.01% 2327
2020
Q2 		$71K Buy
25,947
+514
+2% +$1.43K ﹤0.01% 2289
2020
Q1 		$60K Buy
25,433
+5,646
+29% +$19.2K ﹤0.01% 2271
2019
Q4 		$93K Buy
19,787
+1,996
+11% +$8.17K ﹤0.01% 2274
2019
Q3 		$60K Buy
17,791
+3,392
+24% +$11.2K ﹤0.01% 2275
2019
Q2 		$47K Buy
+14,399
New +$41.7K ﹤0.01% 2547

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Aperio Group's ATRS Position: Q4 2020 in Review

Aperio Group increased its Antares Pharma, Inc. (ATRS) stake by 12% in Q4 2020, buying an estimated $13.3K and bringing the position to 37,381 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #2355.

Aperio Group first reported a position in ATRS in Q2 2019 and has held it in 7 quarters since. 174 funds tracked by Wall St. Rank hold ATRS as of Q4 2020.

  • Aperio Group held 37,381 shares of Antares Pharma, Inc. worth $149K as of Q4 2020.
  • Aperio Group bought 4,105 Antares Pharma, Inc. shares in Q4 2020, an estimated $13.3K.
  • Antares Pharma, Inc. made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2355 holding.
  • Aperio Group first reported a position in Antares Pharma, Inc. in Q2 2019 and has held it in 7 quarters since.
  • 174 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.